160 related articles for article (PubMed ID: 20682647)
1. Tyrosine phosphatase inhibitor-3 sensitizes melanoma and colon cancer to biotherapeutics and chemotherapeutics.
Kundu S; Fan K; Cao M; Lindner DJ; Tuthill R; Liu L; Gerson S; Borden E; Yi T
Mol Cancer Ther; 2010 Aug; 9(8):2287-96. PubMed ID: 20682647
[TBL] [Abstract][Full Text] [Related]
2. MKP1/CL100 controls tumor growth and sensitivity to cisplatin in non-small-cell lung cancer.
Chattopadhyay S; Machado-Pinilla R; Manguan-García C; Belda-Iniesta C; Moratilla C; Cejas P; Fresno-Vara JA; de Castro-Carpeño J; Casado E; Nistal M; Gonzalez-Barón M; Perona R
Oncogene; 2006 Jun; 25(23):3335-45. PubMed ID: 16462770
[TBL] [Abstract][Full Text] [Related]
3. Novel SHP-1 inhibitors tyrosine phosphatase inhibitor-1 and analogs with preclinical anti-tumor activities as tolerated oral agents.
Kundu S; Fan K; Cao M; Lindner DJ; Zhao ZJ; Borden E; Yi T
J Immunol; 2010 Jun; 184(11):6529-36. PubMed ID: 20421638
[TBL] [Abstract][Full Text] [Related]
4. Overcoming hypoxia-induced apoptotic resistance through combinatorial inhibition of GSK-3β and CDK1.
Mayes PA; Dolloff NG; Daniel CJ; Liu JJ; Hart LS; Kuribayashi K; Allen JE; Jee DI; Dorsey JF; Liu YY; Dicker DT; Brown JM; Furth EE; Klein PS; Sears RC; El-Deiry WS
Cancer Res; 2011 Aug; 71(15):5265-75. PubMed ID: 21646472
[TBL] [Abstract][Full Text] [Related]
5. The Hollow Fibre Assay as a model for in vivo pharmacodynamics of fluoropyrimidines in colon cancer cells.
Temmink OH; Prins HJ; van Gelderop E; Peters GJ
Br J Cancer; 2007 Jan; 96(1):61-6. PubMed ID: 17179993
[TBL] [Abstract][Full Text] [Related]
6. The combination of MLN2238 (ixazomib) with interferon-alpha results in enhanced cell death in melanoma.
Suarez-Kelly LP; Kemper GM; Duggan MC; Stiff A; Noel TC; Markowitz J; Luedke EA; Yildiz VO; Yu L; Jaime-Ramirez AC; Karpa V; Zhang X; Carson WE
Oncotarget; 2016 Dec; 7(49):81172-81186. PubMed ID: 27783987
[TBL] [Abstract][Full Text] [Related]
7. Anticancer activity of sodium stibogluconate in synergy with IFNs.
Yi T; Pathak MK; Lindner DJ; Ketterer ME; Farver C; Borden EC
J Immunol; 2002 Nov; 169(10):5978-85. PubMed ID: 12421984
[TBL] [Abstract][Full Text] [Related]
8. Mitogen-activated protein kinase phosphatase-1 inhibition and sustained extracellular signal-regulated kinase 1/2 activation in camptothecin-induced human colon cancer cell death.
Lee M; Young Kim S; Kim J; Kim HS; Kim SM; Kim EJ
Cancer Biol Ther; 2013 Nov; 14(11):1007-15. PubMed ID: 24005240
[TBL] [Abstract][Full Text] [Related]
9. Targeting mitochondria by anthelmintic drug atovaquone sensitizes renal cell carcinoma to chemotherapy and immunotherapy.
Chen D; Sun X; Zhang X; Cao J
J Biochem Mol Toxicol; 2018 Sep; 32(9):e22195. PubMed ID: 30004155
[TBL] [Abstract][Full Text] [Related]
10. Enhanced anti-melanoma efficacy of interferon alfa-2b via inhibition of Shp2.
Win-Piazza H; Schneeberger VE; Chen L; Pernazza D; Lawrence HR; Sebti SM; Lawrence NJ; Wu J
Cancer Lett; 2012 Jul; 320(1):81-5. PubMed ID: 22306001
[TBL] [Abstract][Full Text] [Related]
11. Peginterferon Beta-1a Shows Antitumor Activity as a Single Agent and Enhances Efficacy of Standard of Care Cancer Therapeutics in Human Melanoma, Breast, Renal, and Colon Xenograft Models.
Boccia A; Virata C; Lindner D; English N; Pathan N; Brickelmaier M; Hu X; Gardner JL; Peng L; Wang X; Zhang X; Yang L; Perron K; Yco G; Kelly R; Gamez J; Scripps T; Bennett D; Joseph IB; Baker DP
J Interferon Cytokine Res; 2017 Jan; 37(1):20-31. PubMed ID: 27835061
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of eukaryotic translation initiation factor 4E is effective against chemo-resistance in colon and cervical cancer.
Xi C; Wang L; Yu J; Ye H; Cao L; Gong Z
Biochem Biophys Res Commun; 2018 Sep; 503(4):2286-2292. PubMed ID: 29959920
[TBL] [Abstract][Full Text] [Related]
13. Adenovirus-mediated E2F-1 gene transfer sensitizes melanoma cells to apoptosis induced by topoisomerase II inhibitors.
Dong YB; Yang HL; Elliott MJ; McMasters KM
Cancer Res; 2002 Mar; 62(6):1776-83. PubMed ID: 11912154
[TBL] [Abstract][Full Text] [Related]
14. CC-5079: a small molecule with MKP1, antiangiogenic, and antitumor activity.
Vu HN; Miller WJ; O'Connor SA; He M; Schafer PH; Payvandi F; Muller GW; Stirling DI; Libutti SK
J Surg Res; 2010 Nov; 164(1):116-25. PubMed ID: 19726061
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and molecular mechanisms of novel dual inhibitors of heat shock protein 90/phosphoinositide 3-kinase alpha (Hsp90/PI3Kα) against cutaneous melanoma.
Qin F; Wang Y; Jiang X; Wang Y; Zhang N; Wen X; Wang L; Jiang Q; He G
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):909-926. PubMed ID: 30957641
[TBL] [Abstract][Full Text] [Related]
16. The Aurora kinase inhibitor SNS-314 shows broad therapeutic potential with chemotherapeutics and synergy with microtubule-targeted agents in a colon carcinoma model.
VanderPorten EC; Taverna P; Hogan JN; Ballinger MD; Flanagan WM; Fucini RV
Mol Cancer Ther; 2009 Apr; 8(4):930-9. PubMed ID: 19372566
[TBL] [Abstract][Full Text] [Related]
17. Enhancement by recombinant human interferon alfa of the reversal of multidrug resistance by MRK-16 monoclonal antibody.
Fogler WE; Pearson JW; Volker K; Ariyoshi K; Watabe H; Riggs CW; Wiltrout RH; Longo DL
J Natl Cancer Inst; 1995 Jan; 87(2):94-104. PubMed ID: 7707396
[TBL] [Abstract][Full Text] [Related]
18. A novel oral micellar fenretinide formulation with enhanced bioavailability and antitumour activity against multiple tumours from cancer stem cells.
Orienti I; Salvati V; Sette G; Zucchetti M; Bongiorno-Borbone L; Peschiaroli A; Zolla L; Francescangeli F; Ferrari M; Matteo C; Bello E; Di Virgilio A; Falchi M; De Angelis ML; Baiocchi M; Melino G; De Maria R; Zeuner A; Eramo A
J Exp Clin Cancer Res; 2019 Aug; 38(1):373. PubMed ID: 31439019
[TBL] [Abstract][Full Text] [Related]
19. MKP1 mediates chemosensitizer effects of E1a in response to cisplatin in non-small cell lung carcinoma cells.
Cimas FJ; Callejas-Valera JL; Pascual-Serra R; García-Cano J; Garcia-Gil E; De la Cruz-Morcillo MA; Ortega-Muelas M; Serrano-Oviedo L; Gutkind JS; Sánchez-Prieto R
Oncotarget; 2015 Dec; 6(42):44095-107. PubMed ID: 26689986
[TBL] [Abstract][Full Text] [Related]
20. Impact of Interferon-alpha1b (IFN-α1b) on Antitumor Immune Response: An Interpretation of the Promising Therapeutic Effect of IFN-alpha1b on Melanoma.
Liu Y; Ma J; Yang Y; Liu L; Zhu G; Wang X; Wang S; Guo W; Yue Q; Zhao T; Li C; Gao T; Shi Q
Med Sci Monit; 2020 Mar; 26():e922790. PubMed ID: 32210221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]